Skip to main content
European Commission logo print header

Integrated post-genomic approaches for the understanding, detection and prevention of antifungal drug resistance in fungal pathogens

Cel

The EURESFUN (European RESistance FUNgal) network will utilize genomics-based integrated approaches to study antifungal resistance in relevant fungal pathogens (Candida, Aspergillus). This network will study distinct resistance mechanisms (target mutations , drug efflux, signal transduction, transcriptional activation, cell wall alterations, biofilm formation) all of which can contribute individually or in combination to antifungal resistance in clinical isolates. Using microarray strategies, systematic dele tion/overexpression approaches, the network will also elucidate new resistance mechanisms. This approach will unravel potential novel targets for antifungal drug discovery, but also yield diagnostic tools and mutations suitable for the use in resistance mo nitoring and surveillance. Gene deletion approaches will infer new therapeutic strategies to improve efficacy of existing antifungal therapy, including combination drug therapies to generate synergism. Novel intervention strategies to minimise or bypass re sistance will be validated using animal models. Based on this knowledge, cell-based assays for drug target genes will be established and. used for drug discovery by a SME. To monitor progression of systemic infections and monitor resistance, the consortium will establish a collection of clinical strains representing ä wide range of antifungal susceptibilities. SMEs will pursue the development and validation of reliable diagnostic tools with commercial potential for rapid clinical strain identification and r esistance testing, employing microarray technologies in combination with PCR technologies. Finally this network will establish data on resistance incidence and prevalence and will link clinical data on susceptibility to known antifungals with therapy outco me. Major European reference centers will jointly set up and recommend European standards for resistance definition,resistance testing/prediction/definition,and breakpoint identification

Zaproszenie do składania wniosków

FP6-2004-LIFESCIHEALTH-5
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
Wkład UE
Brak danych
Adres
Rue du Bugnon 48
LAUSANNE
Szwajcaria

Zobacz na mapie

Linki
Koszt całkowity
Brak danych

Uczestnicy (9)